Search Results

Filter
  • 1-10 of  3,422 results for ""Antibiotics, Antitubercular""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Repurposing antibiotics to treat syphilis.

  • Authors : Stafylis C; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Klausner JD

Subjects: Syphilis*/Syphilis*/Syphilis*/drug therapy ; Antibiotics, Antitubercular*; Humans

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Apr; Vol. 24 (4), pp. 335-336. Date of Electronic Publication: 2024 Jan 08.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis.

  • Authors : Garcia-Prats AJ; Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: .

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Mycobacterium tuberculosis* ; Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/therapeutic use

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Jul; Vol. 23 (7), pp. 778-780. Date of Electronic Publication: 2023 May 25.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.

  • Authors : Dhana A; Department of Medicine, University of Cape Town, Cape Town, South Africa.; Hamada Y

Subjects: Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/complications ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Apr; Vol. 22 (4), pp. 507-518. Date of Electronic Publication: 2021 Nov 17.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin.

  • Authors : Mvelase NR; Department of Medical Microbiology, KwaZulu-Natal Academic Complex, National Health Laboratory Service, Level 4, Pathology Laboratory Building, Inkosi Albert Luthuli Central Hospital, Durban 4091, South Africa; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa. Electronic address: .

Subjects: Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/pharmacology ; Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/Antibiotics, Antitubercular*/therapeutic use ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/diagnosis

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Feb; Vol. 22 (2), pp. 156-157. Date of Electronic Publication: 2021 Oct 07.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Severe disseminated tuberculosis in HIV-negative refugees.

  • Authors : Suárez I; Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany; German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany.

Subjects: HIV Infections* ; Refugees*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2019 Oct; Vol. 19 (10), pp. e352-e359. Date of Electronic Publication: 2019 Jun 07.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Discordant results between genotypic and phenotypic assays (Xpert MTB/RIF vs. BACTEC MGIT 960 system) for detection of RIF-resistant Mycobacterium tuberculosis isolates in a high burden region.

  • Authors : Rafael LL; Clínica y Laboratorio de Tuberculosis Hospital General Tijuana, ISESALUD, Tijuana, Baja California, Mexico; Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico

Subjects: Drug Resistance, Bacterial*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*pharmacology ; Diagnostic Tests, Routine/Diagnostic Tests, Routine/Diagnostic Tests, Routine/*instrumentation

  • Source: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2021 Dec; Vol. 96, pp. 105142. Date of Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101084138 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Brucellosis mimicking herpes simplex virus encephalitis.

  • Authors : Pannu AK; Department of Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Saroch A

Subjects: Diagnosis, Differential*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Jan; Vol. 20 (1), pp. 144.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium:

Record details

×
Periodical

New guidelines for latent tuberculosis.

Subjects: Drug Therapy, Combination*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use ; Guidelines as Topic/Guidelines as Topic/Guidelines as Topic/*standards

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 414.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS.

  • Authors : Winchester LC; Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, NE, United States.; Podany AT

Subjects: Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*blood ; Rifabutin/Rifabutin/Rifabutin/*blood ; Rifampin/Rifampin/Rifampin/*analogs & derivatives

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2015 Feb; Vol. 104, pp. 55-61. Date of Electronic Publication: 2014 Nov 18.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluation.

  • Authors : Hoppentocht M; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands. Electronic address: .; Hagedoorn P

Subjects: Drug Discovery*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*administration & dosage ; Tuberculosis, Pulmonary/Tuberculosis, Pulmonary/Tuberculosis, Pulmonary/*drug therapy

  • Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2014 Jan; Vol. 86 (1), Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  3,422 results for ""Antibiotics, Antitubercular""